US Patent 7288633 Modified human thymic stromal lymphopoietin
Patent 7288633 was granted and assigned to Immunex on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Kirk P. Van Ness0
Raymond J. Paxton0
Stewart D. Lyman0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+251 characters)
Article
Patent abstract
Modified, furin resistant human TSLP polypeptides and polynucleotides encoding the modified human TSLP polypeptides are provided. Pharmaceutical compositions, B and T cell activation agents, assays and methods of use are also described.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07288633 Modified human thymic stromal lymphopoietin US Patent 7288633 Modified human thymic stromal lymphopoietin
Infobox
Patent Number
072886330
Patent Number
72886330
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072886330
Date of Patent
October 30, 2007
0Patent Application Number
102026990
Date Filed
July 23, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07288633 Modified human thymic stromal lymphopoietin
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07288633
Date of patent
October 30, 2007
Patent application number
10202699
Date Filed
July 23, 2002
Patent primary examiner
Find more entities like US Patent 7288633 Modified human thymic stromal lymphopoietin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.